Brought to you by 
GeneCentric Diagnostics gets $250k in seed funding
12 Sep 2012
Executive Summary
GeneCentric Diagnostics Inc. has launched with $250k in seed money provided by Hatteras Venture Partners and one other investor. The company, co-founded in early 2011 by University of North Carolina at Chapel Hill researchers Drs. Charles Perou and David Neil Hayes, will develop molecular diagnostics for cancer.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
GeneCentric Diagnostics gets $250k in seed funding
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice